The relaunched retailer's shares surged 7% following its announcement to acquire Tokens.com and launch a new platform by July, leveraging tZERO and Figure's blockchain technology to offer tokenized real estate assets and financial services.
Once a high-flying green energy IPO, Plug Power now trades near historic lows. While its technology powers giants like Amazon and Walmart, mounting losses and a shifting political landscape pose existential questions about its path to profitability.
As QuantumScape shares hover near $10, a stark divergence emerges between its discounted cash flow valuation and its price-to-book ratio. With the stock down year-to-date but up sharply over one year, investors are weighing the promise of solid-state batteries against execution risks and market volatility.
Shares of SoundHound AI have plummeted over 50% in recent months, diverging sharply from its reported strong revenue growth and a massive addressable market. Some analysts argue the pullback has created an undervalued entry point for the voice recognition specialist.
As new leadership takes the helm, battery innovator Amprius Technologies is pivoting its high-energy-density silicon anode technology from niche aerospace applications toward the mass electric mobility market, backed by a new manufacturing strategy and surging revenue.
Once a high-flying AI discovery platform, AbCellera Biologics is navigating a critical transition to a clinical-stage biotech. With a fortified balance sheet and key Phase 1 readouts on the horizon, some investors see a compelling, albeit risky, turnaround story taking shape.
Elon Musk announces the merger of SpaceX and xAI, unveiling an ambitious plan to construct data centers in space, which he claims will become the most cost-effective source of AI computing power within years.
Elon Musk consolidates his space and AI ventures, creating a private sector titan valued at $1.25 trillion with an ambitious plan to address AI's energy demands by moving data centers into orbit.
Terrestrial Energy has entered into an Other Transaction Authority agreement with the U.S. Department of Energy for Project TEFLA, a pivotal initiative to demonstrate and integrate its proprietary IMSR Fuel Salt production into the domestic nuclear supply chain.
The 104-year-old Seattle-based outdoor institution, once boasting nearly 600 stores globally, is reportedly preparing for a Chapter 11 bankruptcy filing that would close its roughly 200 remaining brick-and-mortar locations across the continent.
Amid tightening climate regulations, Southern States LLC launches a new line of high-voltage switching products that replace the potent greenhouse gas SF6 with a readily available blend of carbon dioxide and oxygen, promising a dramatic reduction in environmental impact without compromising grid reliability.
The iconic outdoor apparel brand Eddie Bauer is preparing to file for Chapter 11 bankruptcy and close its physical stores across the U.S. and Canada, marking a decisive shift to a digital-first future while retaining some international retail presence.
The biotech company Grail has formally submitted its Galleri test for FDA premarket approval, a critical step that could unlock widespread insurance reimbursement and integrate the multi-cancer screening tool into mainstream preventive care.
In a strategic reversal, GSK has handed back global rights to the clinical-stage RNA editing drug WVE-006 to Wave Life Sciences. Wave asserts the move allows it to faster advance the potential 'functional cure' for alpha-1 antitrypsin deficiency, while GSK refocuses on broader respiratory markets.
Despite a steep decline from its highs, UiPath's pivot towards agentic AI and a path to sustained profitability is drawing investor scrutiny. We examine its valuation, competitive moat, and growth runway in a crowded field.
In a strategic move to diversify its portfolio and strengthen its European footprint, UK-based The Tofoo Co., backed by private equity, has acquired German seitan specialist Topas, owner of the Wheaty brand.
Pharmaceutical giant Eli Lilly enters a strategic collaboration potentially worth up to $1.93 billion with biotech firm Repertoire Immune Medicines, aiming to develop precision treatments for autoimmune diseases that move beyond broad immunosuppression.
SoundHound AI's shares have retreated to their most affordable level in over a year, presenting a potential entry point for investors betting on the widespread adoption of its conversational AI. While revenue growth is robust, the path to profitability and consumer acceptance of AI agents remain critical hurdles.
Shares of the direct-to-consumer telehealth company Hims & Hers have been halved over the past six months, trading near $27. Investors are now weighing whether the steep sell-off presents a buying opportunity or signals deeper troubles ahead.
Leading Solana DEX aggregator Jupiter has finalized a $35 million strategic investment from ParaFi Capital, with the landmark deal to be settled entirely in its native stablecoin, JupUSD. The move signals strong institutional validation and a push for JupUSD adoption.
